Paul Bottomley of Montana forfeited nearly $6 million in cash and property and was sentenced to five years probation for his role in the scheme that imported fake cancer drugs into US clinics, ultimately reaching patients. Bottomley will also serve five months in home confinement and complete 200 hours of community service as part of his sentence. After selling his company Montana Health Care Solutions (MHCS), Bottomley remained associated with the organization as a consultant and was involved in the sales and distribution of counterfeit Avastin^®, reports the Department of Justice. US Attorney for the District of Montana Michael W. Cotter indicated that Bottomley’s “conduct in this case was motivated by greed. Bottomley utilized the grey market and sold potentially dangerous unapproved and misbranded pharmaceuticals at discounted prices to American physicians all for a healthy profit.” John Roth, director, FDA, Office of Criminal Investigations, stated that the “sentencing was another victory in FDA’s ongoing fight to safeguard Americans from misbranded, adulterated and counterfeit pharmaceuticals,” and that the case is “part of an agency-wide effort to ensure that consumers have access to high quality drugs – and that these medicines are traveling safely through increasingly complex supply chains.” NABP reported on the distribution of fake cancer medication associated with MHCS in a February 2012 NABP e-News article.